Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Elizabeth Comen, MD, an internationally acknowledged breast most cancers oncologist and girls’s well being specialist recognized for her pioneering contributions within the area, has...
FREE WebinarTuesday, September 8, 20205:00 - 6:00 PM, Japanese Commonplace TimeRegister NowHead and neck cancers arising from the higher aerodigestive tract are...
